<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">CREATION OF A MODEL TO PREDICT SURVIVAL IN PATIENTS WITH REFRACTORY COELIAC DISEASE USING A MULTINATIONAL REGISTRY</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-10-01">2017 October 01</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Alberto</forename><surname>Rubio-Tapia</surname></persName>
							<email>rubiotapia.alberto@mayo.edu</email>
							<affiliation key="aff0">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD PhD</roleName><forename type="first">Georgia</forename><surname>Malamut</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Hopital Europeen Georges-Pompidou</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD PhD</roleName><forename type="first">Wieke</forename><forename type="middle">H M</forename><surname>Verbeek</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">VU University Medical Centre</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Roy</forename><forename type="middle">L J</forename><surname>Van Wanrooij</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">VU University Medical Centre</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Daniel</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Beth Israel Deaconess Medical Center</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sonia</forename><forename type="middle">I</forename><surname>Niveloni</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hospital Dr. Carlos Nonorino Udaondo</orgName>
								<address>
									<settlement>Buenos Aires</settlement>
									<country key="AR">Argentina</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Carolina</forename><surname>Arguelles-Grande</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Columbia University Medical Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Brian</forename><forename type="middle">D</forename><surname>Lahr</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Alan</forename><forename type="middle">R</forename><surname>Zinsmeister</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Joseph</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ciaran</forename><forename type="middle">P</forename><surname>Kelly</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Beth Israel Deaconess Medical Center</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>Massachusetts</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Julio</forename><forename type="middle">C</forename><surname>Bai</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Hospital Dr. Carlos Nonorino Udaondo</orgName>
								<address>
									<settlement>Buenos Aires</settlement>
									<country key="AR">Argentina</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Peter</forename><forename type="middle">H</forename><surname>Green</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Columbia University Medical Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD PhD</roleName><forename type="first">Severin</forename><surname>Daum</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Charite-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD PhD</roleName><forename type="first">Chris</forename><forename type="middle">J J</forename><surname>Mulder</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">VU University Medical Centre</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD PhD</roleName><forename type="first">Christophe</forename><surname>Cellier</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Hopital Europeen Georges-Pompidou</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mayo</forename><surname>Clinic</surname></persName>
						</author>
						<author>
							<affiliation key="aff7">
								<address>
									<addrLine>200 First Street SW</addrLine>
									<postCode>55905</postCode>
									<settlement>Rochester</settlement>
									<region>MN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">CREATION OF A MODEL TO PREDICT SURVIVAL IN PATIENTS WITH REFRACTORY COELIAC DISEASE USING A MULTINATIONAL REGISTRY</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-10-01">2017 October 01</date>
						</imprint>
					</monogr>
					<idno type="MD5">D2DD086C56E861D3B79A1672BE011289</idno>
					<idno type="DOI">10.1111/apt.13755</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:23+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>coeliac disease</term>
					<term>diarrhoea</term>
					<term>malabsorption</term>
					<term>small intestine</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background-Refractory coeliac disease is a severe complication of coeliac disease with heterogeneous outcome.</s></p><p><s>Aim-To create a prognostic model to estimate survival of patients with refractory coeliac disease.</s></p><p><s>Methods-We evaluated predictors of 5-year mortality using Cox proportional hazards regression on subjects from a multinational registry.</s><s>Bootstrap re-sampling was used to internally validate the individual factors and overall model performance.</s><s>The mean of the estimated regression coefficients from 400 bootstrap models was used to derive a risk score for 5-year mortality.</s></p><p><s>Results-The multinational cohort was composed of 232 patients diagnosed with refractory coeliac disease across 7 centers (range of 11-63 cases per center).</s><s>The median age was 53 years and 150 (64%) were women.</s><s>A total of 51 subjects died during 5-year follow-up (cumulative 5-</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Coeliac disease (CD) is characterized by intestinal damage induced by the ingestion of gluten in susceptible individuals. <ref type="bibr" target="#b0">1</ref></s><s>Gluten-free diet is an effective therapy for most patients. <ref type="bibr" target="#b1">2</ref></s><s>4]<ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> Failure of expected symptomatic response to gluten-free diet may occur in some patients (5%-30%). <ref type="bibr" target="#b8">9</ref></s><s>Nonresponsive CD is defined by persistent or recurrent gastrointestinal symptoms despite apparent adherence to a gluten-free diet. <ref type="bibr" target="#b9">10</ref></s><s>By far, inadvertent gluten contamination is the most common cause of nonresponsive CD. <ref type="bibr">101112</ref> Other causes of nonresponsive CD include microscopic colitis, exocrine pancreatic insufficiency, lactose intolerance, small-intestine bacterial overgrowth, irritable bowel syndrome, and refractory coeliac disease. <ref type="bibr" target="#b12">13</ref></s><s>Refractory coeliac disease is characterized by persistent [primary] or recurrent [secondary] gastrointestinal symptoms and villous atrophy despite strict adherence to gluten-free diet after exclusion of other causes of nonresponsive CD and overt malignancy. <ref type="bibr">141516</ref></s><s>Refractory celiac disease is rare with a reported prevalence of 0.3%-4%  There are two types of refractory coeliac disease based on the immunophenotype of small-bowel intraepithelial lymphocytes. <ref type="bibr" target="#b14">15</ref> Refrac</s><s>ory coeliac disease type I, in which intraepithelial lymphocytes phenotype is normal (CD7 + ,CD3s + ,CD8 + ,CD3ε + ), and refractory coeliac disease type II, in which there is an abnormal phenotype of intraepithelial lymphocytes (CD7 + ,CD3s − ,CD8 − ,CD3ε + ).</s><s><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> This abnormal cell population can also be recognized by a clonally restricted rearrangement of the T-cell receptor gene by polymerase chain reaction.</s><s>Response to treatment and overall prognosis are thought to be better for refractory coeliac disease type I as compared to refractory coeliac disease type II.  M</s><s>t patients with refractory coeliac disease type I respond well to steroids and/or immunosuppressives.</s><s><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> Conventional pharmacological therapies and more aggressive therapies such as single-agent chemotherapy, and stem-cell transplantation have been proposed for patients with the more severe refractory coeliac disease type II.</s><s>Prognosis of refractory coeliac disease type II is poor because therapies are less effective and high risk of progression to enteropathy-type T-cell lymphoma.</s><s><ref type="bibr">262836</ref> Besides the traditional classification of refractory coeliac disease, few other prognostic factors have been suggested.</s><s><ref type="bibr">2836</ref> The a priori identification of subsets of patients with a higher risk of poor outcome may help to guide surveillance and therapeutic interventions.</s><s>Unfortunately, a disease-specific prognostic model is lacking.</s><s>Thus, there is a crucial need for a prognostic model able to accurately predict mortality among patients with refractory coeliac disease at the time of first presentation.</s></p><p><s>The purpose of the present study was to develop and validate a new model to predict survival in patients with refractory coeliac disease using a multinational cohort.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p><s>The multinational refractory coeliac disease collaborative group consists of a network of seven centers (5 countries) collaborating for research on refractory coeliac disease.</s><s>The multinational refractory coeliac disease registry is a retrospective cohort study established in 2009 to elucidate the outcome of refractory coeliac disease.</s><s>The registry consists of patients diagnosed with RCD between July1984, when the first patient was diagnosed, and December 2009, the cutoff date for entry into this report.</s><s>Most patients (85%) were diagnosed after January1999.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnostic Criteria for Refractory Coeliac Disease</head><p><s>Conventional criteria for classification of the refractory coeliac disease (and types) were used to maximize the correct allocation of patients by categories.  The inclusion c</s><s>teria included: 1) Persistence or recurrence of gastrointestinal symptoms (diarrhea, involuntary loss of weight, and/or abdominal pain) and intestinal damage (at least partial villous atrophy) after gluten exclusion for at least 6months. <ref type="bibr" target="#b38">39</ref></s><s>Asymptomatic patients with persistent intestinal damage were not included as this may represent slow mucosal healing in adults with CD. <ref type="bibr" target="#b39">40</ref> 2) Evidence of dietary inquiry to exclude intentional or inadvertent gluten contamination.</s><s>A negative coeliac-specific serology at time of refractory coeliac disease diagnosis was not required but seem consistent with good compliance to gluten-free diet. <ref type="bibr" target="#b40">41</ref></s><s>3) Need of alternative therapy because of lack of response to gluten-free diet alone.</s><s>4) Absence of overt intestinal or systemic lymphoma at diagnosis of refractory celiac disease.</s><s>5) Previous diagnosis of CD was supported by villous atrophy in small bowel biopsy and positive coeliac serology (tissue transglutaminase or endomysial antibody) and/or history of clinical response to the gluten-free diet. <ref type="bibr">4243</ref></s><s>For the minority of patients without documented positive coeliac serology or clinical response to gluten-free diet, the diagnosis of refractory coeliac disease was supported by permissive human leukocyte antigen DQ2 and/or DQ8 and the exclusion of other known causes of enteropathy. <ref type="bibr">1415323844</ref></s><s>e presence of human leukocyte antigen alleles at-risk for CD DQ2 or DQ8, a family history of CD, and exclusion of other causes of enteropathy were considered supportive for the diagnosis of CD, especially in a minority of patients without either a positive coeliac serology and/or history of clinical response to gluten-free diet [primary refractory coeliac disease]. <ref type="bibr">1384546</ref></s><s>Human leukocyte antigen DQ2 or DQ8 was not routinely required for CD diagnosis and when absent supported a high negative predictive value for CD diagnosis. <ref type="bibr">424346</ref></s><s>Accordingly, when patients were tested, the presence of human leukocyte antigen DQ2 and/or DQ8 was required for inclusion.</s></p><p><s>Refractory coeliac disease type was determined by the absence (refractory coeliac disease type I) or presence (refractory coeliac disease type II) of an abnormal phenotype of intraepithelial lymphocyte determined by immunohistochemistry, flow cytometry, and/or Tcell clonality analyses.</s></p><p><s><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Collection</head><p><s>Clinical and laboratory data were collected from the medical record.</s><s>Participant centers incorporated clinical information of their cases with refractory coeliac disease into a standardized electronic database as a common method for collection of information.</s><s>At a coordinating center (Mayo Clinic), control and supervision of all clinical data received was undertaken with communication with all participant centers for clarification (and resolution) of data inconsistencies.</s><s>Additionally, endoscopy, imaging, and pathology data were supplied by each center.</s><s>Histological findings were categorized using the modified Marsh classification. <ref type="bibr" target="#b56">57</ref></s><s>Immunohistochemistry and T-cell clonality studies used to identify abnormal immunophenotype or clonal expansion of intraepithelial lymphocytes in the intestinal biopsy were included. <ref type="bibr">1520</ref></s><s>At the time of data collection, flow cytometry was used routinely for assessment of refractory celiac disease in few participant centers. 1522</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of Clonal Expansion of Abnormal Intraepithelial Lymphocytes</head><p><s>The presence of abnormal intraepithelial lymphocytes was evaluated in fixed or fresh frozen intestinal tissue by the following methods: i) abnormal immunophenotype was defined by the lack of expression of the surface markers CD3 and CD8, with preserved expression of the cytoplasmic CD3 (CD3ε) in &gt;50% of intraepithelial lymphocytes using immunohistochemistry or &gt;20% using flow cytometry as previously described, <ref type="bibr">2022</ref> and ii) clonality studies by detection of T-cell receptor-γ rearrangement by polymerase chain reaction or southern blot. <ref type="bibr">1523</ref></s><s>It is not possible to differentiate between surface (CD3s) or cytoplasmic CD3 (CD3ε) using immunohistochemistry, flow cytometry can overcome this limitation. <ref type="bibr" target="#b21">22</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Descriptive statistics on baseline variables are presented as median (range), mean (standard deviation), or count (percentage) as appropriate.</s><s>Seven a priori selected variables were evaluated as predictors of 5-year mortality with multiple variable Cox proportional hazards regression.</s><s>Variables were selected based on prior single-center reports of potential outcome implications in refractory celiac disease.</s><s>Preliminary analysis showed that results from regression models pooling across all centers did not differ appreciably compared to those from models that stratified on center and for brevity and ease of interpretability only the pooled results are reported.</s><s>We assumed that data missing-ness occurred at random and used single imputation to predict unknown values of body mass index, albumin, hemoglobin and intraepithelial lymphocyte status (% missing ranged from 6 to 14%).</s><s>A p-spline plot of the mortality hazard function against a smoothed version of each continuous variable was used to assess the adequacy of a linear relationship.</s><s>Interactions between either age or intraepithelial lymphocyte status and other candidate risk factors were pre-specified as clinically meaningful and for both the corresponding group of interaction terms was simultaneously tested for significance (i.e., likelihood ratio test with 6 degrees of freedom) to avoid inflating type 1 error.</s><s>All analyses were carried out with the statistical software package SAS, version 9.1 (SAS Institute, Cary, NC, USA), except for the p-spline plots which were done in R, version 2.13.0 (R Development Core Team, Vienna, Austria).</s></p><p><s>To internally validate the individual risk factors and overall model performance, bootstrap resampling was used. <ref type="bibr" target="#b57">58</ref></s><s>For each of the 400 bootstrap resamples (selected via random sampling from the original set of patients, with replacement), we fit a multiple variable Cox proportional hazards model using the same 7 predictors and obtained the survival concordance index (c-statistic) as a measure of model performance. <ref type="bibr">5960</ref></s><s>We then tested this bootstrap model on the original data and re-measured its performance.</s><s>Bias was estimated as the average difference in c-statistic values between the bootstrap and test models, which was then subtracted from the "apparent" measure (i.e., model c-statistic from original model fit) to obtain a bias-corrected concordance index.</s><s>To visually assess calibration, which is the model's ability to accurately predict the absolute level of risk that is subsequently observed, deciles of predicted survival from the Cox proportional hazards model were plotted against the empirical survival rates obtained from the Kaplan-Meier method.</s></p><p><s>For each factor in the model, the average estimated regression coefficients from the 400 bootstrap resamples were used to weight its contribution to the prediction score.</s><s>The point value contribution to the prediction score for each factor, was calculated by dividing each coefficient by the minimum absolute value among all significant coefficients in the model (note some continuous variables were re-parameterized to express their effect on a more meaningful scale), and then rounded to the nearest integer.</s><s>A subject's risk score is simply the cumulative number of points from factor included in the model, with higher scores corresponding to increased risk of 5-year mortality.</s></p><p><s>To demonstrate that the simplified risk score adequately summarized the multiple variable model, a univariate Cox proportional hazards model with the risk score as the predictor variable was fit and its c-statistic was compared to that of the multiple variable model.</s><s>In addition, the original multivariable model predicted 5-year survival estimates were plotted against corresponding estimates from the risk score model, and the agreement was assessed using Lin's concordance correlation coefficient.. <ref type="bibr" target="#b60">61</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethical Issues</head><p><s>This study was approved by the Institutional Review Boards of all participant centers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p><s>A total of 21 subjects were excluded from the original cohort of 253 patients, 20 because of "prevalent" enteropathy-type T-cell lymphoma (Paris, n=5; Argentina, n=4; New York, n= 4; Amsterdam, n=3; Boston, n=2; Rochester, n=1; and Berlin, n=1) and 1 because of no followup information (Boston, n=1).</s><s>In the final analysis set of 232 patients, median age was 53 years (range, 15-88 years), and 150 (64%) were women.</s><s>The diagnosis of CD was supported by presence of villous atrophy (212/212, 100%) including Marsh 3a 19 (8%), Marsh 3b 23 (11%), Marsh 3c 106 (50%), Marsh 3 no otherwise specified 64 (31%); at least one positive coeliac serology (IgA tissue transglutaminase or endomysial antibody) at the time of CD diagnosis (97/148, 66%); human leukocyte antigen DQ2 and/or DQ8 (158/158, 100%), and clinical response to gluten-free diet before refractory celiac diagnosis (148/228, 65%).</s><s>Moreover, 189/231 (82%) patients have had either documented positive coeliac serology (IgA tissue transglutaminase or endomysial antibody) or documented clinical response to gluten-free diet.</s></p><p><s>At the time of refractory celiac disease diagnosis, immunohistochemistry was performed in 219 (94%) and positive in 111 (51%), T-cell receptor-γ rearrangement test was performed in 185 (80%) and positive in 109 (60%), and flow cytometry was performed in 101 (43%) and positive in 62 (61%).</s><s>Overall agreement between immunohistochemistry and flow cytometry was good (kappa 0.75; 95% confidence interval 0.63-0.88)</s><s>but only fair for both immunohistochemistry and flow cytometry with T-cell receptor-γ rearrangement test (kappa 0.58; 95% confidence interval 0.46-0.70 and 0.41; 95 confidence interval 0.21-0.60,</s><s>respectively).</s><s>The median number of cases by participant center was 28 (range, 11-63).</s><s>Despite significant differences in several baseline characteristics across the seven participant centers, the rates of 5-year mortality did not differ significantly (p=0.41).</s><s>The 232 patients were followed from their date of refractory coeliac disease diagnosis until either death or last day of follow-up (median duration of 3.2 years; interquartile, 1.4-6.0</s><s>years).</s><s>During a truncated follow-up period of 5 years, a total of 51 subjects died (Kaplan-Meier survival rate 70%).</s><s>Table <ref type="table" target="#tab_0">1</ref> Refractory coeliac disease-related mortality was the most common cause of death.</s><s>Table <ref type="table" target="#tab_3">2</ref> Predictor Variables All study variables were evaluated as potential predictors of 5-year mortality using Cox proportional hazards regression.</s><s>From p spline plots, most of the continuous variables demonstrated a linear relationship with the hazard function and therefore were not transformed for the regression modeling.</s><s>For hemoglobin, the relationship was generally linear except at its upper range when the hazard function sharply decreased, likely due to a paucity of high values in the cohort (the majority of subjects were below the normal range).</s></p><p><s>To satisfy linearity we transformed hemoglobin by capping values at the lower bounds of the normal range (14 g/dL for males and 12 g/dL for females) From a multiple variable model that included all 7 hypothesized risk factors, increased age at diagnosis (p&lt;.001), decreased albumin (p&lt;.001), and abnormal intraepithelial lymphocyte (p=0.015) were each significantly associated with 5-year mortality (model c-statistic=0.750).</s><s>Table <ref type="table" target="#tab_4">3</ref> To address the possibility of differential associations according to either age or intraepithelial lymphocyte status, we tested the corresponding group of interaction terms for significance but observed no overall differences in our model results (p=0.73 and p=0.07 from tests of group interactions for age and, separately, for intraepithelial lymphocyte with other candidate risk factors).</s><s>As a sensitivity analysis, exclusion of 9 patients with enteropathytype T cell lymphoma diagnosed within 12 months of refractory coeliac disease diagnosis resulted in no appreciable differences in the model estimates or performance (c-statistic=0.746).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Internal Validation of Regression Modeling</head><p><s>To estimate the optimism bias in the original model fit and then compute a bias-corrected cstatistic, each bootstrap-selected model was tested against the original data and its performance assessed.</s><s>Compared to the apparent discrimination (c-statistic 0.750) of the multiple variable model, the bias-corrected c-statistic of 0.717 indicates a modest amount of optimism bias from the original model fit, though still a fair discriminative ability by the model.</s><s>Furthermore, to assess calibration of the model, the 2-year predictions were divided into deciles and the average predicted survival versus the empirical survival rates estimated by the Kaplan-Meier method were plotted (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Since the identity line (or Y=X, which represents perfect calibration) falls within the 95% confidence limits of the empirical estimate for each decile, the model was deemed to be adequately calibrated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Deriving the Risk Score</head><p><s>Two different versions of a prediction score were ultimately constructed and compared for estimating the risk of 5-year mortality in refractory coeliac disease patients.</s><s>In the first version, a weighted point system was derived that used the regression coefficients but ignored the statistical significance of the factors (5-factor risk score).</s><s>In the final multiple variable model, point values were assigned as the re-scaled coefficient rounded to the nearest integer (note that a point value estimating to 0 ultimately means the factor is not incorporated into the scoring tool).</s><s>Applying this algorithm, the first risk score assigned a variable number of points for the three significant factors depending on their values, and one point each for indication of male gender and total villous atrophy despite both not being significantly associated with 5-year mortality (Table <ref type="table">4</ref>).</s><s>In addition, a second risk score (3factor risk score) was considered that incorporated only the point assignments for the three significant factors (identical to the original scoring except gender and villous atrophy are assigned no points), and compared its prognostic utility to that of the 5-factor risk score.</s></p><p><s>Relative to the apparent discrimination measured from the original multiple variable model (c statistic=0.750),</s><s>both the 5-and 3-factor risk scores demonstrated fairly comparable measures of discrimination (c statistic=0.739</s><s>and 0.731, respectively).</s><s>From scatterplots of predicted 5-year survival rates from the original multiple variable model plotted against those from each of the two risk score models, an excellent concordance in both and only marginal decrement in agreement from the simpler 3-factor risk score was observed (Lin's concordance correlation coefficient=0.964 and 0.940, respectively, Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>Furthermore, discrimination of the 3-factor risk score was illustrated by dividing the predictions in quartiles, and plotting the Kaplan-Meier curves of these four groups.</s><s>Note there is noticeably poorer survival among subjects in the third quartile (risk score of 8 or 9; Kaplan-Meier rate at 5 years, 60.5%; 95% confidence interval, 39.9%-74.3%)</s><s>and fourth quartile (risk score ≥10; Kaplan-Meier rate at 5 years, 48.5%; 95% confidence interval, 33.3%-61.7%)</s><s>relative to those in the first (risk score of 0-4; Kaplan-Meier rate at 5 years, 97.6%; 95% confidence interval, 62.2%-99.7%)</s><s>and second (risk score 5-7; Kaplan-Meier rate at 5 years, 83.2%; 95% confidence interval, 66.1%-92.0%)</s><s>quartiles (p&lt;.001, Figure <ref type="figure" target="#fig_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>We developed a prognostic model for refractory coeliac disease to predict 5-year mortality among patients with refractory coeliac disease.</s><s>The 3-factor risk score requires simple clinical variables such as age at diagnosis of refractory coeliac disease, albumin in serum, and immunophenotype of intraepithelial lymphocyte in a biopsy of the duodenum.</s></p><p><s>Currently, the type of refractory coeliac disease based on the immunophenotype of intraepithelial lymphocyte is used to stratify patients into prognostic subgroups. <ref type="bibr">2628</ref></s><s>lassification of refractory coeliac disease is based on the immunophenotype and clonality of intraepithelial lymphocyte of the small bowel. <ref type="bibr">152022</ref></s><s>We found good agreement between immunohistochemistry and flow cytometry but fair agreement between both immunohistochemistry and flow cytometry with T-cell receptor-γ rearrangement.</s><s>Testrelated performance limitations should be taken into account when the immunophenotype of intraepithelial lymphocytes is used as single factor to predict outcome in refractory celiac disease.</s><s>Although this classification may be useful to estimate the risk of progression to lymphoma (e.g., higher risk in refractory coeliac disease type II), <ref type="bibr">262836</ref> another limitation is that tends to treat all patients the same regardless of presence of other risk factors such as age at diagnosis and/or albumin level.</s></p><p><s>A major advantage of our proposed model is the use of commonly available clinical predictors (age, albumin, and immunophenotype of intraepithelial lymphocytes) and thus the proposed model is easy to apply in everyday practice.</s><s>This model was developed using a large and geographically dispersed group of patients suggesting it may be widely applicable.</s><s>We anticipate continued improvement and refinement of the current model.</s><s>The 3-factor risk score is preferable over the more complex 5-factor risk score because of its simplicity and similar discrimination power.</s><s>A model with a c-statistic over 0.7 can be considered clinically useful, for example, the widely used MELD (Model for End-Stage Liver Disease) score has a c-statistic of 0.85. <ref type="bibr" target="#b61">62</ref></s><s>Our 3-factor risk model c-statistic was 0.731.</s><s>The present form of the model may be useful to counsel patients with refractory coeliac disease and might help clinicians to guide treatment decisions and/or follow-up.</s><s>For example, individual patient survival probability at time of refractory coeliac disease diagnosis can be used for risk stratification.</s><s>A low score (0-7) with estimated 5-year Kaplan-Meier survival of 83%-98% make reasonable a more conservative treatment whereas a high score (≥8) with estimated 5year Kaplan-Meier survival of 48%-61% may justify more intensive monitoring and increasingly aggressive interventions.</s><s>In addition, the new model can be very useful to stratify patients according prognosis at the time of enrollment in clinical trials for novel drugs for refractory coeliac disease.</s></p><p><s>The proposed prognostic factors may lead to poor outcome by diverse mechanisms.</s><s>Refractory celiac disease-related mortality explained most deaths in our cohort.</s><s>Abnormal intraepithelial lymphocytes have been extensively studied as risk factor for development of enteropathy-type T-cell lymphoma. <ref type="bibr" target="#b14">15</ref></s><s>Enteropathy-type T-cell lymphoma is associated with a poor prognosis despite therapy although there is evidence of improvement in survival with a novel regimen of chemotherapy followed by autologous stem-cell transplantation. <ref type="bibr">264851</ref></s><s>nteropathy-type T-cell lymphoma was the most frequent cause of death in our cohort explaining 35% of all deaths and seen almost exclusively in patients with abnormal intraepithelial lymphocytes.</s><s>Targeted therapies that may decrease the risk of progression of refractory coeliac disease to enteropathy-type T-cell lymphoma are urgently needed. <ref type="bibr" target="#b32">33</ref></s><s>Low serum albumin was a very strong negative prognostic factor in patients with refractory coeliac disease, although non-specific, it may be a measure of severity of disease, ongoing inflammation of the small bowel, and/or malnutrition commonly associated with other frequent causes of death such as intestinal failure and severe infectionsVigorous nutritional support has been recommended and frequently used in patients with RCD. <ref type="bibr">14283663</ref></s><s><ref type="bibr" target="#b65">[66]</ref> It is possible that other variables not included in the current model may increase robustness of the prognostic model in the near future (e.g., human leukocyte antigens, gene-expression profiles or "molecular signatures" and/or proportion of aberrant cells by flow cytometry). <ref type="bibr" target="#b35">36</ref></s><s>deed, the presence of ≥80% CD3ε + CD3s − CD8 − intraepithelial lymphocytes by immunohistochemistry has been reported as a predictor of enteropathy-type T-cell lymphoma development in refractory coeliac disease. <ref type="bibr" target="#b24">25</ref></s><s>Lymphomagenesis in refractory coeliac disease is a complex process and refinement of prognostic models toward individualized medicine will require a better understanding of the underlying molecular mechanisms. <ref type="bibr" target="#b66">67</ref></s><s>Survival signals to intraepithelial lymphocytess in refractory coeliac disease require IL-15 and depend on the anti-apoptosis factor BcL-xL. <ref type="bibr" target="#b67">68</ref> Different stages of maturity of intraepithelial lymphocytess in refractory coeliac disease may determine the size of the risk of progression to lymphoma and hence long-term prognosis. <ref type="bibr" target="#b68">69</ref></s><s>A lineage-negative CD3s − CD7 + CD3ε + CD127 − CD34 − IL-15 responsive subset of lymphocytes may represent the physiological counterpart of abnormal cells associated with refractory celiac disease type II-associated lymphoma. <ref type="bibr" target="#b69">70</ref></s><s>udy limitations include the retrospective nature of data and variable laboratory evaluation of patients across participant centers.</s><s>However, clinical evidence for a prior diagnosis of CD was necessary for inclusion.</s><s>Similar operational definition as well as exclusion criteria helped to mitigate heterogeneity.</s><s>In fact, 5-year mortality rate was similar among participant centers and a pooled analysis was feasible and desirable.</s><s>We did not use separate derivation and validation datasets due to rarity of refractory coeliac disease.</s><s>Thus, prospective validation is advisable..</s><s>In conclusion, these data suggest that the new simplified 3-factor risk score that includes age, albumin, and immunophenotype of intraepithelial lymphocytes is able to accurately predict 5-year mortality among patients with refractory coeliac disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Model Calibration Plot</head><p><s>Footnote Figure <ref type="figure" target="#fig_0">1</ref>: predicted survival was captured both from the apparent model and the bootstrap (bias-corrected) model.</s><s>Dots convey the apparent calibration from the original model, while x portray bias-corrected calibration from the bootstrap models.</s><s>For a reference of perfect calibration, the Y=X line is displayed.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc><div><p><s>FIGURE 1.</s></p></div></figDesc><graphic coords="14,84.16,62.00,503.68,378.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 2 .</head><label>2</label><figDesc><div><p><s>FIGURE 2.Agreement between Predicted Survival from Multivariable and Risk Score Models: Panel A) 5-Factor Risk Score and Panel B) 3-Factor Risk Score</s></p></div></figDesc><graphic coords="16,84.16,62.00,503.68,378.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 3 .</head><label>3</label><figDesc><div><p><s>FIGURE 3.</s></p></div></figDesc><graphic coords="17,84.16,62.00,503.68,378.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc><div><p><s>Demographic, Clinical and Follow-Up Data for Patients with Refractory Coeliac Disease</s></p></div></figDesc><table><row><cell></cell><cell>p value</cell><cell>&lt;0.001</cell></row><row><cell>7.Amsterdam</cell><cell>(N=46)</cell><cell></cell><cell>60.2 (9.15)</cell></row><row><cell>3.Paris 4.NY 5.Boston 6.Rochester</cell><cell>(N=63) (N=18) (N=25) (N=42)</cell><cell></cell><cell>49.2 (12.61) 52.8 (15.37) 51.4 (17.67) 57.6 (13.26)</cell></row><row><cell>2.Bueno Aires</cell><cell>(N=28)</cell><cell></cell><cell>46.1 (10.72)</cell></row><row><cell>1.Berlin</cell><cell>(N=11)</cell><cell></cell><cell>59.5 (17.52)</cell></row><row><cell>Total</cell><cell>(N=233)</cell><cell></cell><cell>53.5 (13.85)</cell></row><row><cell></cell><cell></cell><cell>Age at RCD Dx</cell><cell>Mean (SD)</cell><cell>Median</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p><s>Cause of Death in Patients with Refractory Coeliac Disease Thrombosis/ischemia (pro-thrombotic state) has been reported in refractory celiac disease β* Other includes giant cell myocarditis, suicide, unexplained progressive encephalitis (n=3), and gastrointestinal bleeding</s></p></div></figDesc><table><row><cell>Cause of Death</cell><cell>All Patients</cell><cell>RCD type 1</cell><cell>RCD type 2</cell></row><row><cell></cell><cell>(n=51)</cell><cell>(n=10)</cell><cell>(n=41)</cell></row><row><cell>Refractory celiac disease-related mortality</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Intestinal failure (emaciation and/or persistent malabsorption)</cell><cell>7</cell><cell>3</cell><cell>4</cell></row><row><cell>Enteropathy type T-cell lymphoma</cell><cell>18</cell><cell>1</cell><cell>17</cell></row><row><cell>Severe infection or sepsis</cell><cell>12</cell><cell>3</cell><cell>9</cell></row><row><cell>Refractory celiac disease-unrelated mortality</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Thrombosis/ischemia α</cell><cell>6</cell><cell>1</cell><cell>5</cell></row><row><cell>Other β*</cell><cell>6</cell><cell>1</cell><cell>5</cell></row><row><cell>Unknown</cell><cell>2</cell><cell>1</cell><cell>1</cell></row><row><cell>α</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE 3</head><label>3</label><figDesc><div><p><s>Risk of 5-year Mortality from the Original Multivariable Model</s></p></div></figDesc><table><row><cell></cell><cell>Hazard Ratio (95%</cell></row><row><cell></cell><cell>confidence interval) [p-</cell></row><row><cell>Variable</cell><cell>value]</cell></row><row><cell>Age at refractory coeliac disease</cell><cell>2.21 (1.38, 3.55) [&lt;.001]</cell></row><row><cell>dx (per 20 yr increase)</cell><cell></cell></row><row><cell>Male Gender</cell><cell>1.48 (0.84, 2.61) [0.172]</cell></row><row><cell cols="2">Body mass index (per 5 unit increase) * 0.95 (0.64, 1.42) [0.813]</cell></row><row><cell>Hemoglobin *</cell><cell>0.98 (0.87, 1.12) [0.804]</cell></row><row><cell>Albumin (per 0.5 unit increase) *</cell><cell>0.72 (0.61, 0.85) [&lt;.001]</cell></row><row><cell>Total Villous Atrophy *</cell><cell>1.26 (0.71, 2.24) [0.423]</cell></row><row><cell cols="2">Abnormal intraepithelial lymphocytes  † 2.85 (1.22, 6.62) [0.015]</cell></row><row><cell>Model C-statistic</cell><cell>0.750 *imputation</cell></row><row><cell>used to fill in missing data</cell><cell></cell></row></table><note><p><s>^bias-corrected c-statistic of 0.717 † Defined by immunohistochemistry and/or clonality studies</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Aliment Pharmacol Ther. Author manuscript; available in PMC 2017 October 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>Grant support: Supported by NIH DK-57892 (to JAM), NIH 3R01DK57892-9S2 and American College of Gastroenterology Junior Faculty Development Award (to A.R.T).</s><s>This publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).</s><s>Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CD</head><p><s>coeliac disease</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Celiac disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1731" to="1743" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17960014</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Gluten-free diet: the medical and nutrition management of celiac disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>See</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Clin Pract</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16439765</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Malignancy and mortality in people with coeliac disease: population based cohort study</title>
		<author>
			<persName><forename type="first">J</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Logan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bmj</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="issue">7468</biblScope>
			<biblScope unit="page" from="716" to="719" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 15269095</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Small-intestinal histopathology and mortality risk in celiac disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ludvigsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ekbom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jama</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1171" to="1178" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19755695</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Causes of death in patients with celiac disease in a populationbased Swedish cohort</title>
		<author>
			<persName><forename type="first">U</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Askling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gridley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1566" to="1572" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12860579</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mortality in patients with coeliac disease and their relatives: a cohort study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Corrao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Corazza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bagnardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="issue">9279</biblScope>
			<biblScope unit="page" from="356" to="361" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11502314</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Causes of death in people with celiac disease spanning the preand post-serology era: a population-based cohort study from Derby, UK</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Grainge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Card</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="933" to="939" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21245833</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Eslick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aliment Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="540" to="551" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22239821</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Refractory coeliac disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Daum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mulder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="413" to="424" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15925846</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Etiology of nonresponsive celiac disease: results of a systematic approach</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Abdulkarim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Burgart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>See</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2016" to="2021" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12190170</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Etiologies and predictors of diagnosis in nonresponsive celiac disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hyett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="445" to="450" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17382600</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Celiac disease: management of persistent symptoms in patients on a gluten-free diet</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Dewar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Mclaughlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1348" to="1356" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22493548</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Celiac disease and persistent symptoms</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="17" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>quiz e8. PubMed: 20692372</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Classification and management of refractory coeliac disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="547" to="557" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20332526</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Refractory sprue, coeliac disease, and enteropathyassociated T-cell lymphoma. French Coeliac Disease Study Group</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delabesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="issue">9225</biblScope>
			<biblScope unit="page" from="203" to="208" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10963198</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Refractory celiac disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastrointestinal endoscopy clinics of North America</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="759" to="772" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23083992</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Celiac disease and its complications: a time traveller&apos;s perspective</title>
		<author>
			<persName><forename type="first">J</forename><surname>West</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="32" to="34" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19041868</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The incidence and clinical spectrum of refractory celiac disease in a north american referral center</title>
		<author>
			<persName><forename type="first">B</forename><surname>Roshan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jamma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="923" to="928" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21468013</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ilus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kaukinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Virta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aliment Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">24387637</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method</title>
		<author>
			<persName><forename type="first">N</forename><surname>Patey-Mariaud De Serre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jabri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="70" to="77" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10931221</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Verbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Blomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Coupe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytometry B Clin Cytom</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="367" to="374" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19444812</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Verbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Goerres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Blomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="48" to="56" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18024205</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Abnormal intestinal intraepithelial lymphocytes in refractory sprue</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Patey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mauvieux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="471" to="481" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9496937</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ashton-Key</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Diss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="493" to="498" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>PubMed: 9250161</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease</title>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lavergne-Slove</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="452" to="460" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 19996326</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Survival in refractory coeliac disease and enteropathyassociated T-cell lymphoma: retrospective evaluation of single-centre experience</title>
		<author>
			<persName><forename type="first">Al-Toma A</forename><surname>Verbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Hadithi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1373" to="1378" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17470479</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">High rates of complications and substantial mortality in both types of refractory sprue</title>
		<author>
			<persName><forename type="first">S</forename><surname>Daum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ipczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schumann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="66" to="70" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19011576</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Afchain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Verkarre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="81" to="90" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19014942</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Budesonide in the treatment of refractory celiac disease</title>
		<author>
			<persName><forename type="first">P</forename><surname>Brar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2265" to="2269" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17581265</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Therapy with budesonide in patients with refractory sprue</title>
		<author>
			<persName><forename type="first">S</forename><surname>Daum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ipczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Heine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestion</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="60" to="68" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16612091</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Azathioprine and prednisone combination therapy in refractory coeliac disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Goerres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Wahab</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aliment Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="487" to="494" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12950421</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Novel approaches in the management of refractory celiac disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Verbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Rev Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="205" to="219" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 20477051</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cerf-Bensussan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1320" to="1321" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 17110301</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Cladribine therapy in refractory celiac disease with aberrant T cells</title>
		<author>
			<persName><forename type="first">Al-Toma A</forename><surname>Goerres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1322" to="1327" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>quiz 00. PubMed: 16979946</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells</title>
		<author>
			<persName><forename type="first">Al-Toma A</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Van Roessel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2243" to="2249" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17068146</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Clinical staging and survival in refractory celiac disease: a single center experience</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lahr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="352" to="353" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 18996383</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Refractory celiac disease</title>
		<author>
			<persName><forename type="first">H</forename><surname>Abdallah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dennis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Gastroenterol Rep</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="401" to="405" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17991341</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Defining gluten refractory enteropathy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Biagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Corazza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="561" to="565" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11396537</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The Oslo definitions for coeliac disease and related terms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ludvigsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="52" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 22345659</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Rahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>See</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1412" to="1420" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20145607</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Serological tests for celiac disease as indicators of longterm compliance with the gluten-free diet</title>
		<author>
			<persName><forename type="first">F</forename><surname>Nachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sugai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vazquez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European journal of gastroenterology &amp; hepatology</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="473" to="480" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21537123</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ludvigsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Biagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1210" to="1228" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24917550</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">ACG clinical guidelines: diagnosis and management of celiac disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The American journal of gastroenterology</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="656" to="676" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23609613</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Pallav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tariq</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aliment Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="380" to="390" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22145590</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Update on serologic testing in celiac disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Leffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schuppan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2520" to="2524" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 21131921</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">HLA-DQ typing in the diagnosis of celiac disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kaukinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Partanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="695" to="699" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 11922565</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Simmonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Mead</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="795" to="803" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10673521</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Evaluation of enteropathy associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplant</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sieniawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Angamuthu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Boyd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="3664" to="3670" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20197551</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Chandesris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Verkarre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterol Clin Biol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="590" to="605" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 21050687</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Halfdanarson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Ristow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1042" to="1047" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20851210</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main">Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Chandesris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Verkarre</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="377" to="384" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Adult autoimmune enteropathy: Mayo Clinic Rochester experience</title>
		<author>
			<persName><forename type="first">S</forename><surname>Akram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Pardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1282" to="1290" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17683994</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Verkarre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Suarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2262" to="2275" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20551941</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Talley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Gurudu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="344" to="349" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20060071</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Severe spruelike enteropathy associated with olmesartan</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rubio-Tapia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Herman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ludvigsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clinic proceedings Mayo Clinic</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="732" to="738" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Tropical sprue</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Nath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Gastroenterol Rep</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="343" to="349" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16168231</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Histopathology of celiac disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Oberhuber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Pharmacother</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="368" to="372" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10989975</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Efron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Stat</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="36" to="48" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">The meaning and use of the area under a receiver operating characteristic (ROC) curve</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Mcneil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="29" to="36" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note>PubMed: 7063747</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Model for end-stage liver disease (MELD) and allocation of donor livers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wiesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="91" to="96" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12512033</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A Concordance Correlation-Coefficient to Evaluate Reproducibility</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="255" to="268" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note>PubMed: 2720055</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts</title>
		<author>
			<persName><forename type="first">M</forename><surname>Malinchoc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kamath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Gordon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="864" to="871" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10733541</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">The management of complicated celiac disease</title>
		<author>
			<persName><forename type="first">Al-Toma A</forename><surname>Verbeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dig Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="230" to="236" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17827946</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Transection of the oesophagus for bleeding oesophageal varices</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Pugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Murray-Lyon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Dawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Surg</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">4541913</biblScope>
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Komrokji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Corrales-Yepez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kharfan-Dabaja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hematol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1006" to="1009" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23090887</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study</title>
		<author>
			<persName><forename type="first">I</forename><surname>Holme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Fellstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Jardin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of internal medicine</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="463" to="471" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 21812843</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Refractory celiac disease: from bench to bedside</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Meresse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cellier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Immunopathol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="601" to="613" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22810901</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Malamut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>El Machhour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Montcuquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2131" to="2143" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20440074</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Origin and immunophenotype of aberrant IEL in RCDII patients</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Tack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Van Wanrooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Langerak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Immunol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="262" to="270" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22364936</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Tjon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="509" to="519" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 22760007</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
